Next generation diagnostics of heritable connective tissue disorders

Area of Science:

• Molecular Genetics
• Genomic Medicine
• Bioinformatics

Background:

• Identifying pathogenic mutations is crucial for understanding monogenic diseases, aiding genetic counseling, disease modeling, and therapeutic development.
• Traditional mutation detection methods like genetic linkage and candidate gene analysis are often laborious and costly.
• Next-generation sequencing (NGS) technologies are transforming gene discovery and mutation detection.

Purpose of the Study:

• To highlight the impact of next-generation sequencing on identifying pathogenic mutations in monogenic diseases.
• To discuss the advantages of whole-exome and whole-genome sequencing in diagnostics and novel disease-gene association discovery.
• To explore the future role of NGS in clinical genetics and personalized medicine.

Main Methods:

• Application of whole-exome sequencing (WES) and whole-genome sequencing (WGS).
• Utilizing next-generation sequencing for mutation detection in inherited diseases with genetic heterogeneity.
• Analysis of bioinformatics data for improved diagnostic sensitivity and disease-gene association.

Main Results:

• NGS improves diagnostic sensitivity and identifies novel disease-gene associations.
• NGS is a cost-effective method for mutation detection in genetically heterogeneous inherited diseases.
• Advancements in sequencing cost reduction, run time, and bioinformatics are driving NGS adoption in clinical genetics.

Conclusions:

• NGS is poised to become a routine diagnostic tool in clinical genetics.
• In the short term, NGS will enhance mutation documentation for disorders like heritable connective tissue disorders.
• Long-term, bioinformatics analysis of NGS data will offer insights into prognosis and enable personalized therapeutics.